|

|
# Augentropfen Stulln Mono is a product of Pharma Stulln GmbH,
Germany, and Shenzhen Kangzhe Pharmeutical Co., Ltd. is the sole distributor
of the product in P. R China
# As an eye-drop, Stulln can be used in the treatment of senile macular
degeneration, retinal macular-related disease and all kinds of ocular
asthenopia
# After the acquisition of the exclusive distribution right for Augentropfen
Stulln Mono in China by CMS in 2007, the product is expected to be
marketed with a market acceptable price |
|